LeddarTech Releases Its LeddarSteer Automotive-Grade, Solid-State Digital Beam Steering Technology for LiDAR Sensor Developers
May 10, 2022 00:07 ET | LeddarTech inc.
QUEBEC, May 10, 2022 (GLOBE NEWSWIRE) -- LeddarTech®, a global leader in providing the most flexible, robust and accurate ADAS and AD sensing technology, is pleased to announce the official release...
LeddarTech lance LeddarSteer, la technologie solid-state d’orientation numérique du faisceau de classe automobile pour les développeurs de capteurs LiDAR
May 10, 2022 00:07 ET | LeddarTech inc.
QUÉBEC, 10 mai 2022 (GLOBE NEWSWIRE) -- LeddarTech®, chef de file de calibre mondial en technologie de détection précise, robuste et polyvalente pour les systèmes avancés d’aide à la conduite...
Deep Brain Stimulation Devices Market to Exhibit a CAGR of 11.6% by 2026; Rising Geriatric Population to Enable Expansion, states Fortune Business Insights™
June 19, 2020 10:14 ET | Fortune Business Insights
Pune, June 19, 2020 (GLOBE NEWSWIRE) -- The global deep brain stimulation devices market size is expected to reach USD 1,676.8 million by 2026, exhibiting a CAGR of 11.6% during the forecast...
Deep Brain Stimulation for Treatment-Resistant Depression: A Progress Report - A Free Webinar from the Brain & Behavior Research Foundation
September 18, 2019 09:00 ET | Brain & Behavior Research Foundation
New York, Sept. 18, 2019 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation is hosting a free interactive webinar on “Deep Brain Stimulation for Treatment-Resistant Depression: A...
Rising Prevalence of Neurological Diseases Driving the Neuromodulation Devices Market Growth; to Witness a CAGR of 10.3% during 2019-2025
June 04, 2019 09:23 ET | Energias Market Research
NEW YORK, June 04, 2019 (GLOBE NEWSWIRE) -- The global neuromodulation devices market is expected to grow significantly from USD 5,120 Million in 2018 to USD 10,200 Million in 2025, at a CAGR of...
Adamas Announces Publication of Amantadine Immediate Release Subgroup Analysis From EASE LID 2 Open-label Study in Movement Disorders Clinical Practice
February 08, 2018 09:00 ET | Adamas Pharmaceuticals, Inc.
EMERYVILLE, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced that subgroup analyses of Parkinson’s disease patients taking amantadine immediate...
ClearPoint-13169-Final-Logo-CMYK jpg.jpg
Zero DBS Electrode Infections Reported When Utilizing the ClearPoint® NeuroNavigation System in an MRI Suite
April 20, 2016 09:00 ET | ClearPoint Neuro, Inc.
IRVINE, Calif., April 20, 2016 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) today announced the results of a 10 year study in which Deep Brain Stimulation (DBS) leads were implanted in...
ClearPoint-13169-Final-Logo-CMYK jpg.jpg
MRI Interventions Reports 2014 Financial Results
March 05, 2015 16:00 ET | ClearPoint Neuro, Inc.
IRVINE, Calif., March 5, 2015 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC), a commercial stage medical device company focused on creating innovative platforms for performing the next...
Mazor Robotics Renaissance(R) Guidance System Helping Patients with OCD
March 05, 2015 06:10 ET | Mazor Robotics
ORLANDO, Fla., March 5, 2015 (GLOBE NEWSWIRE) -- Mazor Robotics (www.mazorrobotics.com), a global leader in the development and distribution of innovative surgical guidance systems for spine and brain...
ClearPoint-13169-Final-Logo-CMYK jpg.jpg
MRI Interventions Exhibiting Its Advanced Neurosurgical Navigation Platform, the ClearPoint Neuro Intervention System, at AANS 2013 Annual Meeting
April 29, 2013 08:00 ET | ClearPoint Neuro, Inc.
NEW ORLEANS, April 29, 2013 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) today announced that its ClearPoint® Neuro Intervention System is on exhibit at the 2013 Annual Meeting of the...